Logo image of EYE

NATIONAL VISION HOLDINGS INC (EYE) Stock Fundamental Analysis

USA - NASDAQ:EYE - US63845R1077 - Common Stock

28.87 USD
-0.39 (-1.33%)
Last: 10/3/2025, 8:00:02 PM
28.87 USD
0 (0%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

3

EYE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. While EYE is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, EYE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EYE had positive earnings in the past year.
In the past year EYE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EYE reported negative net income in multiple years.
EYE had a positive operating cash flow in each of the past 5 years.
EYE Yearly Net Income VS EBIT VS OCF VS FCFEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With a Return On Assets value of -0.72%, EYE perfoms like the industry average, outperforming 42.62% of the companies in the same industry.
EYE has a Return On Equity (-1.66%) which is comparable to the rest of the industry.
EYE's Return On Invested Capital of 2.65% is in line compared to the rest of the industry. EYE outperforms 47.54% of its industry peers.
EYE had an Average Return On Invested Capital over the past 3 years of 1.97%. This is significantly below the industry average of 11.93%.
The last Return On Invested Capital (2.65%) for EYE is above the 3 year average (1.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROIC 2.65%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
EYE Yearly ROA, ROE, ROICEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

EYE has a Operating Margin (2.76%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EYE has declined.
EYE has a better Gross Margin (58.61%) than 86.89% of its industry peers.
EYE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 58.61%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
EYE Yearly Profit, Operating, Gross MarginsEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EYE is destroying value.
The number of shares outstanding for EYE has been increased compared to 1 year ago.
EYE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for EYE has been reduced compared to a year ago.
EYE Yearly Shares OutstandingEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EYE Yearly Total Debt VS Total AssetsEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.34 indicates that EYE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EYE has a Altman-Z score (2.34) which is in line with its industry peers.
EYE has a debt to FCF ratio of 4.80. This is a neutral value as EYE would need 4.80 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.80, EYE is doing good in the industry, outperforming 64.75% of the companies in the same industry.
EYE has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
EYE's Debt to Equity ratio of 0.30 is in line compared to the rest of the industry. EYE outperforms 58.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Altman-Z 2.34
ROIC/WACC0.29
WACC9.24%
EYE Yearly LT Debt VS Equity VS FCFEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

EYE has a Current Ratio of 0.52. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EYE (0.52) is worse than 91.80% of its industry peers.
A Quick Ratio of 0.31 indicates that EYE may have some problems paying its short term obligations.
EYE's Quick ratio of 0.31 is on the low side compared to the rest of the industry. EYE is outperformed by 73.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.31
EYE Yearly Current Assets VS Current LiabilitesEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
EYE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.68% yearly.
EYE shows a decrease in Revenue. In the last year, the revenue decreased by -4.45%.
The Revenue has been growing slightly by 1.12% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%

3.2 Future

Based on estimates for the next years, EYE will show a very strong growth in Earnings Per Share. The EPS will grow by 21.75% on average per year.
Based on estimates for the next years, EYE will show a small growth in Revenue. The Revenue will grow by 5.71% on average per year.
EPS Next Y26.89%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EYE Yearly Revenue VS EstimatesEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
EYE Yearly EPS VS EstimatesEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

EYE is valuated quite expensively with a Price/Earnings ratio of 48.12.
EYE's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.86, EYE is valued quite expensively.
With a Price/Forward Earnings ratio of 34.53, EYE can be considered very expensive at the moment.
EYE's Price/Forward Earnings ratio is in line with the industry average.
EYE is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 48.12
Fwd PE 34.53
EYE Price Earnings VS Forward Price EarningsEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EYE is on the same level as its industry peers.
61.48% of the companies in the same industry are more expensive than EYE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 40.3
EV/EBITDA 18.07
EYE Per share dataEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

EYE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as EYE's earnings are expected to grow with 21.75% in the coming years.
PEG (NY)1.79
PEG (5Y)N/A
EPS Next 2Y23.3%
EPS Next 3Y21.75%

0

5. Dividend

5.1 Amount

EYE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NATIONAL VISION HOLDINGS INC

NASDAQ:EYE (10/3/2025, 8:00:02 PM)

After market: 28.87 0 (0%)

28.87

-0.39 (-1.33%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners108.99%
Inst Owner Change-1.98%
Ins Owners1.95%
Ins Owner Change5.45%
Market Cap2.29B
Analysts81.33
Price Target29.43 (1.94%)
Short Float %12.01%
Short Ratio4.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.89%
Min EPS beat(2)9.52%
Max EPS beat(2)30.26%
EPS beat(4)4
Avg EPS beat(4)34.01%
Min EPS beat(4)9.52%
Max EPS beat(4)83.55%
EPS beat(8)8
Avg EPS beat(8)45.05%
EPS beat(12)11
Avg EPS beat(12)16.75%
EPS beat(16)15
Avg EPS beat(16)81.36%
Revenue beat(2)2
Avg Revenue beat(2)1.45%
Min Revenue beat(2)0.41%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)8
Avg Revenue beat(16)-0.24%
PT rev (1m)0%
PT rev (3m)46.45%
EPS NQ rev (1m)2.15%
EPS NQ rev (3m)12.23%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)7.54%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 48.12
Fwd PE 34.53
P/S 1.21
P/FCF 40.3
P/OCF 15.8
P/B 2.69
P/tB N/A
EV/EBITDA 18.07
EPS(TTM)0.6
EY2.08%
EPS(NY)0.84
Fwd EY2.9%
FCF(TTM)0.72
FCFY2.48%
OCF(TTM)1.83
OCFY6.33%
SpS23.81
BVpS10.74
TBVpS-1.21
PEG (NY)1.79
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROCE 3.36%
ROIC 2.65%
ROICexc 2.74%
ROICexgc 7.41%
OM 2.76%
PM (TTM) N/A
GM 58.61%
FCFM 3.01%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
ROICexc(3y)2.16%
ROICexc(5y)4.2%
ROICexgc(3y)5.73%
ROICexgc(5y)11.7%
ROCE(3y)2.5%
ROCE(5y)4.55%
ROICexcg growth 3Y-36.81%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-36.88%
ROICexc growth 5Y-10.66%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
F-Score6
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Debt/EBITDA 1.82
Cap/Depr 99.27%
Cap/Sales 4.66%
Interest Coverage 2.69
Cash Conversion 102.87%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.31
Altman-Z 2.34
F-Score6
WACC9.24%
ROIC/WACC0.29
Cap/Depr(3y)109.9%
Cap/Depr(5y)102.38%
Cap/Sales(3y)5.81%
Cap/Sales(5y)5.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
EPS Next Y26.89%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A
EBIT growth 1Y58.39%
EBIT growth 3Y-39.25%
EBIT growth 5Y-13.48%
EBIT Next Year203.78%
EBIT Next 3Y52.22%
EBIT Next 5YN/A
FCF growth 1Y80.13%
FCF growth 3Y-38.43%
FCF growth 5Y-9.78%
OCF growth 1Y0.91%
OCF growth 3Y-19.78%
OCF growth 5Y-4.14%